A vutrisiran sodium (25 0.5/syringe) 3 syringes,b elapegademase (genetical recombination) (2.4 1.5/

Tender Notice

Tender Detail
A vutrisiran sodium (25 0.5/syringe) 3 syringes,b elapegademase (genetical recombination) (2.4 1.5/vial) 22 vials,c atezolizumab (genetical recombination) (1200 20.0/vial) 35 vials,d pembrolizumab (genetical recombination) (100 4/vial) 204 vials,e
Tendering Authority
Tender Category
Other
Publish Date
28 Mar 2024
Deadline
15 May 2024
Country
Japan
TenderNews Ref. No.
2726816240328-0
Document Fees
Refer Document.
EMD
Refer Document.
Tender Value
Refer Document.
« Previous Tender      Next Tender »

Some of Our Valuable Clients